BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

KV Pharmaceutical Appoints Former Wyeth Research (New Jersey) (WYE) President, Joe Mahady to Chairman of the Board


10/3/2013 7:23:46 AM

biotech jobs post your resume Help employers find you! Check out all the jobs and post your resume.

ST. LOUIS, Oct. 3, 2013 /PRNewswire/ -- K-V Pharmaceutical Company ("KV") today announced the appointment of Joseph M. Mahady as Chairman of its Board of Directors. Previously, Mahady served as Senior Vice President of Wyeth, LLC, and President of Wyeth Pharmaceuticals, Inc., where he led the company's $20 billion global pharmaceutical business. During his tenure, he oversaw the successful launch of more than 30 products in multiple therapeutic areas. Mahady has held various board positions, including Immunex, Albemarle, EKR Therapeutics, Discovery Labs and Cortendo AB.

"Joe's extensive knowledge and expertise in women's healthcare will play a critical role in establishing a renewed focus at the company," said Greg Divis, CEO of KV. "We are fortunate to have Joe's leadership as we continue to grow our business and deliver high quality women's healthcare products."

"I am excited to be joining KV at this particular time," said Mahady. "There is perhaps no more exciting time in a company's evolution than when it moves beyond adversity and applies the knowledge gained from that experience to strengthen the emerging company. KV is in that position today."

Last month, KV announced it had emerged from Chapter 11 bankruptcy. The appointment of Mahady as Chairman is an important part of the company's effort to add depth to its Board of Directors and build upon its portfolio of FDA-approved women's healthcare products. KV will be announcing additional new members of its Board of Directors in the coming weeks.

About KV Pharmaceutical

K-V Pharmaceutical Company is a specialty branded pharmaceutical company with a primary focus in the area of women's healthcare. The company is committed to advancing the health of women across the stages of their lives. For further information about K-V Pharmaceutical Company, please visit www.kvph.com.

SOURCE K-V Pharmaceutical Company



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES